Pricing Log in Create free account

ARS Pharmaceuticals, Inc. (SPRY) vs Vogenx Inc (VOGX)

ARS Pharmaceuticals, Inc. and Vogenx Inc are both Biotechnology companies. ARS Pharmaceuticals, Inc. and Vogenx Inc are of similar size ($270.8M and $263.5M). Across the 2 metrics below, ARS Pharmaceuticals, Inc. leads on 1 and Vogenx Inc on 1.

Valuation

Metric SPRY VOGX Biotechnology median
P/E n/m — 10.60
P/S 2.29 n/m 9.40
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 2.57 n/m 9.02
Earnings yield (71.89%) — (32.88%)
Free cash flow yield (70.96%) 0.00% (23.13%)

Profitability

Metric SPRY VOGX Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin (161.50%) — 0.00%
Net margin 0.00% — 0.00%
Free cash flow margin (149.89%) — 0.00%
Return on equity 0.00% — (51.96%)
Return on assets 0.00% — (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric SPRY VOGX Biotechnology median
Revenue growth (TTM) (14.45%) — 6.76%
EPS growth (last fiscal year) (2,275.00%) — 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric SPRY VOGX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.25 0.44 4.97
Net debt to EBITDA 0.42 — 1.01

Dividend

Metric SPRY VOGX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric SPRY VOGX Biotechnology median
Market cap 263.53m 270.81m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack